Common Sub-Domain::MaterialName

: Public Class

Created:	6/25/2010 4:31:09 PM
Modified:	8/9/2018 10:51:21 PM

Project:
Author:	BRIDG SCC
Version:	1.0
Phase:	1.0
Status:
Complexity:	Easy
Difficulty:
Priority:
Multiplicity:
Advanced:
UUID:	{DEE99B48-C0AA-4597-863E-862D48A9B724}
Appears In:	UML-Based Comprehensive BRIDG Model Diagram, View AE: Adverse Event, View CM: Common, View RG: Regulatory, View IM: Imaging, Product, DICOM SR TID 1500 BRIDG Class Diagram, Oncology & Imaging View, SDTM 3.1.3 View, SDTM Exposure (EX) Domain View, ClinicalTrials.gov, Anatomic Pathology Structured Report (APSR)

DEFINITION: The non-unique textual identification of a material in a specified context. EXAMPLE(S): OTHER NAME(S): NOTE(S):

Attributes
Associations To
Tagged Values

Attribute

Public TN
name

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:0 to 1
Transient:	False
Derived:	False
IsID:	False

Map:AE=Product.name
Map:AE=Component.name
Map:AE=Ingredient.name
Map:AE=Package.name
Map:AIM v4 rv48=Equipment.manufacturerModelName
Map:APSRv2.1=[Problem] hl7:organizer - [Problem] hl7:organizer > hl7:participant > CHOICE OF PLAYING DEVICE OR PLAYING ENTITY > hl7:playingDevice > hl7:manufacturerModelName
Map:APSRv2.1=hl7:entryRelationship [CDA Supply Container] - hl7:entryRelationship [CDA Supply Container] > hl7:supply > hl7:product > hl7:manufacturedProduct > hl7:manufacturedMaterial > hl7:name
Map:APSRv2.1=[Problem] hl7:organizer - [Problem] hl7:organizer > hl7:component [Any kind of AP observation] > hl7:observation > hl7:participant > CHOICE OF PLAYING DEVICE OR PLAYING ENTITY > hl7:playingDevice > hl7:softwareName
Map:APSRv2.1=hl7:author - hl7:author > hl7:assignedAuthor > CHOICE OF ASSIGNED PERSON OR DEVICE > hl7:assignedAuthoringDevice > hl7:manufacturerModelName
Map:APSRv2.1=[Problem] hl7:organizer - [Problem] hl7:organizer > hl7:component [Any kind of AP observation] > hl7:observation > hl7:participant > CHOICE OF PLAYING DEVICE OR PLAYING ENTITY > hl7:playingDevice > hl7:manufacturerModelName
Map:APSRv2.1=hl7:author - hl7:author > hl7:assignedAuthor > CHOICE OF ASSIGNED PERSON OR DEVICE > hl7:assignedAuthoringDevice > hl7:softwareName
Map:caAERSv2.2=MedicalDevice.commonName
Map:caAERSv2.2=MedicalDevice.brandName
Map:caAERSv2.2=ConcomitantMedication.agentName
Map:caAERSv2.2=Agent.name
Map:CDASHv1.1=CM.CMTRT
Map:CDASHv1.1=SU.SUTRT
Map:CDASHv1.1=EX.EXTRT
Map:CTGOV=Other Names
Map:CTOM=Agent.name
Map:CTR&Rr2=Device name
Map:CTR&Rr2=IMP Trade name
Map:CTR&Rr2=IMP Name
Map:CTR&Rr2=IMP Code
Map:CTR&Rr2=AS other descriptive name
Map:CTR&Rr2=AS INN
Map:CTRPv1.0=Biologic.alternateName
Map:CTRPv1.0=Device.name
Map:CTRPv1.0=Drug.alternateName
Map:CTRPv1.0=Drug.name
Map:CTRPv1.0=Cosmetic.alternateName
Map:CTRPv1.0=FoodProduct.alternateName
Map:CTRPv1.0=Material.name
Map:CTRPv1.0=Biologic.name
Map:CTRPv1.0=FoodProduct.name
Map:CTRPv1.0=Product.name
Map:CTRPv1.0=Cosmetic.name
Map:CTRPv1.0=Device.alternateName
Map:CTRR=Comparator(s) product name(s)
Map:CTRR=Intervention Name
Map:CTRRr3=Material.name
Map:CTRv1.0=MaterialName.name
Map:DICOM=Equipment Specification Module - Model Specification Sequence (0018,9912) > Manufacturer's Model Name (0008,1090)
Map:DICOM=TID 1004 DeviceObserverIdentifyingAttributes > Device Observer Name
Map:DICOM=General Equipment Module - Manufacturer's Model Name (0008,1090)
Map:DICOM=TID 1004 DeviceObserverIdentifyingAttributes > Device Observer Model Name
Map:FDA HL7 SD SD DSTU2012=manufacturedMaterial.name
Map:HCTv1.0=CDE 3057651:Therapies.Specify the other retinoids given:
Map:HCTv1.0=CDE 2794436:Therapies.Specify the agent types received for infection prophylaxis:
Map:HCTv1.0=CDE 2741578:Drug or Chemical.What anticoagulants were added to the product during collection?
Map:HCTv1.0=CDE 2787667:Therapies.Specify the in vivo immunotoxin administered:
Map:HCTv1.0=CDE 2787579:Therapies.Specify the other in vivo monoclonal antibody administered:
Map:HCTv1.0=CDE 2775819:Therapies.What was the specific erythropoietin drug administered?
Map:HCTv1.0=CDE 2775782:Therapies.Type(s) of hematopoietic growth factor or cytokine agents given:
Map:HCTv1.0=CDE 2974115:Therapies.Specify the drug used to induce aplastic anemia:
Map:HCTv1.0=CDE 2594484:Pharmacologic Substance.Specify the other agent used after the start of the preparative regimen to prevent acute GVHD or graft rejection
Map:HCTv1.0=CDE 2775817:Therapies.What was the specific G-CSF drug administered?
Map:HCTv1.0=CDE 2741610:Therapies.Specify the other type of the radiolabeled monoclonal antibody preparative regimen:
Map:HCTv1.0=CDE 2816469:Disease, Disorder or Finding.Specify the drugs pharmacokinetics were performed on to determine dosing:
Map:HCTv1.0=CDE 2740356:Therapies.What kind of additives are included in volume of infused product?
Map:HCTv1.0=CDE 2794100:Therapies.Specify the other agent received for infection prophylaxis:
Map:HCTv1.0=CDE 2861458:Therapies.Specify other cytokine:
Map:HCTv1.0=CDE 2786707:Diagnostic, Therapeutic, and Research Equipment.Specify other cell selection system
Map:HCTv1.0=CDE 2958252:Therapies.What type of corticosteroids were administered for the preparative regimen?
Map:HCTv1.0=CDE 2960478:Therapies.What type of nitrosourea compound was administered?
Map:HCTv1.0=CDE 2787876:Therapies.Specify the other agent administered:
Map:HCTv1.0=CDE 2740983:Therapies.Specify the other type of preparative regimen medication:
Map:HCTv1.0=CDE 2960398:Therapies.What was the other drug given for the preparative regimen?
Map:HCTv1.0=CDE 2741589:Therapies.Specify the other anticoagulants
Map:HCTv1.0=CDE 2775844:Therapies.What was the other hematopoietic, lymphoid growth factors, or cytokines administered?
Map:HCTv1.0=CDE 2860920:Therapies.Specify the other monoclonal antibody:
Map:HCTv1.0=CDE 3057634:Therapies.Specify the other radioisotope given:
Map:HCTv1.0=CDE 2594466:Pharmacologic Substance.Specify the other in vivo monoclonal antibody used after the start of the preparative regimen to prevent acute GVHD or graft rejection
Map:HCTv1.0=CDE 2960392:Therapies.What was the type of intrathecal chemotherapy given for the preparative regimen?
Map:HCTv1.0=CDE 2816476:Disease, Disorder or Finding.Specify other drug pharmacokinetics performed on to determine dosing:
Map:HCTv1.0=CDE 2741515:Therapies.Specify the other type of the monoclonal antibody preparative regimen:
Map:HCTv1.0=CDE 2787872:Therapies.Specify the blinded randomized trial agent administered:
Map:HCTv1.0=CDE 2746348:Techniques.Specify other CD3 antibody:
Map:HCTv1.0=CDE 2780779:Therapies.Specify the other additives that are included in volume of infused product
Map:HL7SD=Product.name
Map:ICSRr2=PackagedProduct.name (in R_Product)
Map:ICSRr2=NamedEntity.name (in R_Product)
Map:ICSRr2=Substance.name (in R_Product)
Map:ICSRr2=MaterialKind.name (in R_Product)
Map:ICSRr2=Product.name (in R_Product)
Map:ICSRr2=DeviceInstance.manufacturerModelName (in R_Product)
Map:ICSRr2=DeviceInstance.softwareName (in R_Product)
Map:LSDAMv2.2.3Plus=Container.name
Map:LSDAMv2.2.3Plus=MaterialName.name
Map:LSDAMv2.2.3Plus=Place.locatorValue
Map:LSDAMv2.2.3Plus=Software.name
Map:NCI CRF Standard=CDE 2179777v2.0: Concomitant Agent Name
Map:NCI CRF Standard=CDE 2871652v1.0: Ingredient Name
Map:NCI CRF Standard=CDE 10v4.0: Agent Name
Map:PGx v1.0=PB.PBDRUG
Map:SDTM IGv3.1.1=CM.CMTRT
Map:SDTM IGv3.1.1=SU.SUDECOD
Map:SDTM IGv3.1.1=SU.SUTRT
Map:SDTM IGv3.1.1=EX.EXTRT
Map:SDTM IGv3.1.1=CM.CMDECOD
Map:SDTM IGv3.1.2=CM.CMTRT
Map:SDTM IGv3.1.2=EX.EXTRT
Map:SDTM IGv3.1.2=TS.TSVAL where TSPARMCD=CURTRT
Map:SDTM IGv3.1.2=SU.SUTRT
Map:SDTM IGv3.1.3=TS.TSVALNF WHERE TSPARMCD = "CURTRT"
Map:SDTM IGv3.1.3=TS.TSVALNF WHERE TSPARMCD = "COMPTRT"
Map:SDTM IGv3.1.3=TS.TSVAL WHERE TSPARMCD = "CURTRT"
Map:SDTM IGv3.1.3=TS.TSVAL WHERE TSPARMCD = "COMPTRT"
Map:SDTM IGv3.1.3=EX.EXTRT
Map:SDTM IGv3.1.3=TS.TSVALCD WHERE TSPARMCD = "CURTRT"
Map:SDTM IGv3.1.3=TS.TSVALNF WHERE TSPARMCD = "TRT"
Map:SDTM IGv3.1.3=TS.TSVAL WHERE TSPARMCD = "TRT"

Notes:

DEFINITION: A non-unique textual identifier for the material. EXAMPLE(S): The therapeutic agent used in a chemotherapy clinical trial. OTHER NAME(S): NOTE(S):

Public CD
typeCode

Details:

Alias:
Initial:
Stereotype:
Ordered:
Range:	Range:0 to 1
Transient:	False
Derived:	False
IsID:	False

Map:caAERSv2.2=MedicalDevice.brandName
Map:CTRv1.0=MaterialName.typeCode
Map:LSDAMv2.2.3Plus=MaterialName.typeCode

Notes:

DEFINITION: A coded value specifying the kind of material name. EXAMPLE(S): brand name OTHER NAME(S): NOTE(S):

Element	Source Role	Target Role
«DEPRECATED» RegulatoryAuthority Class	Name: approvedMaterialName	Name: approvingRegulatoryAuthority
Details: DESCRIPTION:<br/>Each MaterialName might be approved by one RegulatoryAuthority. Each RegulatoryAuthority might approve one or more MaterialName.<br/><br/>DEFINITION:<br/><br/>EXAMPLE(S):<br/><br/>OTHER NAME(S):<br/><br/>NOTE(S):<br/><br/>
Material Class	Name: namingMaterialName	Name: namedMaterial
Details: DESCRIPTION:<br/>Each MaterialName always names one Material. Each Material always is named by one or more MaterialName.<br/><br/>DEFINITION:<br/><br/>EXAMPLE(S):<br/><br/>OTHER NAME(S):<br/><br/>NOTE(S):<br/><br/>

Tag	Value
Map:APSRv2.1	[Problem] hl7:organizer - [Problem] hl7:organizer > hl7:participant > CHOICE OF PLAYING DEVICE OR PLAYING ENTITY > hl7:playingDevice > hl7:softwareName
Details:
Map:CTRv1.0	MaterialName
Details:
Map:ICSRr2	NamedEntity (in R_Product)
Details:
Map:LSDAMv2.2.3Plus	MaterialName
Details: